(5S,8R)-HBV-IN-10

Modify Date: 2025-08-25 00:44:44

(5S,8R)-HBV-IN-10 Structure
(5S,8R)-HBV-IN-10 structure
Common Name (5S,8R)-HBV-IN-10
CAS Number 2716907-15-0 Molecular Weight 433.48
Density N/A Boiling Point N/A
Molecular Formula C23H24FN7O Melting Point N/A
MSDS N/A Flash Point N/A

 Use of (5S,8R)-HBV-IN-10


(5S,8R)-HBV-IN-10 is an enantiomer of compound 6 (WO2021204258A1). Compound 6 is a hepatitis B surface antigen (HBsAg) inhibitor (0.001 μM< EC50 ≤0.05 μM). From patent WO2021204258A1, compound 6[1].

 Names

Name (5S,8R)-HBV-IN-10

 (5S,8R)-HBV-IN-10 Biological Activity

Description (5S,8R)-HBV-IN-10 is an enantiomer of compound 6 (WO2021204258A1). Compound 6 is a hepatitis B surface antigen (HBsAg) inhibitor (0.001 μM< EC50 ≤0.05 μM). From patent WO2021204258A1, compound 6[1].
Related Catalog
References

[1]. Azabicyclo compound as hepatitis b surface antigen inhibitor. WO2021204252A1.

 Chemical & Physical Properties

Molecular Formula C23H24FN7O
Molecular Weight 433.48
InChIKey QSALRAHTLYHGOT-QWNRATHESA-N
SMILES COC1CCN(c2cc(F)nc(N3C4CCC3c3cnc(-c5ncccn5)nc3C4)c2)C1
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.
Top Suppliers:I want be here


Get all suppliers and price by the below link:

(5S,8R)-HBV-IN-10 suppliers

(5S,8R)-HBV-IN-10 price

Related Compounds: More...
HBV-IN-10
2716907-16-1
[(5S,8R,9S,10S,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl] N-(2-chloroethyl)-N-nitroso-carbamate
54025-35-3
[(5S,8R,9S,10S,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl] cyclohexanecarboxylate
20592-38-5
(5S,8R)-5-allyl-2,2,3,3,10,10,11,11-octamethyl-8-(4-methylpentyl)-4,9-dioxa-3,10-disiladodecane
875570-75-5
(5S,8R,9S,10S,13S,14S,17S)-17-ethynyl-3,3-difluoro-10,13-dimethyl-2,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ol
2448-69-3
(5S,8R,9S,10S,13S,14S,17S)-3-(1-cyclopenta-2,4-dienylidene)-10,13,17-trimethyl-2,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ol
6952-09-6
[(5S,8R,9S,10S,13S,14S,17S)-13-methyl-3-oxo-2,4,5,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
33767-87-2
(5S,8R)-4,4,8-trimethyl-1-oxaspiro[4.5]dec-6-en-2-one
679396-13-5
(5S,8R,9R,10S)-(+)-(13E)-labd-13-ene-8,15-diol
3649-91-0
1-[3-(4-Chlorophenyl)-5-methyl-2-(trifluoromethyl)pyrazolo[1,5-A]pyrimidin-7-YL]-4-(pyridin-2-YL)piperazine
932987-97-8
3-(4-chlorophenyl)-N-(2-methoxyethyl)-5-methyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyrimidin-7-amine
950345-76-3
N-butyl-3-(4-chlorophenyl)-5-methyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyrimidin-7-amine
932988-07-3
3-(4-chlorophenyl)-5-methyl-N-[2-(morpholin-4-yl)ethyl]-2-(trifluoromethyl)pyrazolo[1,5-a]pyrimidin-7-amine
950301-01-6
3-(4-Chlorophenyl)-5-methyl-7-(4-methylpiperidin-1-yl)-2-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine
933250-95-4
3-(4-chlorophenyl)-5-methyl-N-[3-(morpholin-4-yl)propyl]-2-(trifluoromethyl)pyrazolo[1,5-a]pyrimidin-7-amine
933020-64-5
4-{[3-(4-Chlorophenyl)-5-methyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyrimidin-7-yl]amino}benzamide
950391-73-8
1-[3-(2-Chlorophenyl)-5-methyl-2-(trifluoromethyl)pyrazolo[1,5-A]pyrimidin-7-YL]-4-(pyridin-2-YL)piperazine
932988-26-6
3-(2-chlorophenyl)-5-methyl-N-phenyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyrimidin-7-amine
932988-30-2
3-(2-chlorophenyl)-N-(2-methoxyethyl)-5-methyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyrimidin-7-amine
933251-07-1